[HTML] plos.org

[HTML][HTML] Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve

I Moon, TH Go, JY Kim, DR Kang, SH Sohn, HJ Lee… - Plos one, 2022 - journals.plos.org
Background Non-vitamin K direct oral anticoagulant (DOAC) is effective for prevention of
embolic events in nonvalvular atrial fibrillation (AF) patients. However, the effectiveness and …
被引用次数：5 相关文章

Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve

I Moon, TH Go, JY Kim, DR Kang, SH Sohn… - PLoS …, 2022 - ui.adsabs.harvard.edu
Background Non-vitamin K direct oral anticoagulant (DOAC) is effective for prevention of
embolic events in nonvalvular atrial fibrillation (AF) patients. However, the effectiveness and …

Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve

I Moon, TH Go, JY Kim, DR Kang, SH Sohn… - PloS …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Non-vitamin K direct oral anticoagulant (DOAC) is effective for prevention of
embolic events in nonvalvular atrial fibrillation (AF) patients. However, the effectiveness and …

Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve.

I Moon, TH Go, JY Kim, DR Kang, SH Sohn… - PLoS …, 2022 - search.ebscohost.com
Background: Non-vitamin K direct oral anticoagulant (DOAC) is effective for prevention of
embolic events in nonvalvular atrial fibrillation (AF) patients. However, the effectiveness and …
[HTML] nih.gov

[HTML][HTML] Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve

I Moon, TH Go, JY Kim, DR Kang, SH Sohn, HJ Lee… - PLoS ONE, 2022 - ncbi.nlm.nih.gov
Background Non-vitamin K direct oral anticoagulant (DOAC) is effective for prevention of
embolic events in nonvalvular atrial fibrillation (AF) patients. However, the effectiveness and …

Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve.

I Moon, TH Go, JY Kim, DR Kang, SH Sohn, HJ Lee… - Plos one, 2022 - europepmc.org
Background Non-vitamin K direct oral anticoagulant (DOAC) is effective for prevention of
embolic events in nonvalvular atrial fibrillation (AF) patients. However, the effectiveness and …

Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve

I Moon, TH Go, JY Kim, DR Kang, SH Sohn, HJ Lee… - 2022 - scholarworks.bwise.kr
Background Non-vitamin K direct oral anticoagulant (DOAC) is effective for prevention of
embolic events in nonvalvular atrial fibrillation (AF) patients. However, the effectiveness and …

Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve

I Moon, TH Go, JY Kim, DR Kang, SH Sohn, HJ Lee… - PLoS ONE, 2022 - s-space.snu.ac.kr
© 2022 Moon et al. This is an open access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction …

Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve

I Moon, TH Go, JY Kim, DR Kang, SH Sohn… - PLoS …, 2022 - snucm.elsevierpure.com
Background Non-vitamin K direct oral anticoagulant (DOAC) is effective for prevention of
embolic events in nonvalvular atrial fibrillation (AF) patients. However, the effectiveness and …